Gastroesophageal reflux disease: Control of symptoms, prevention of complications

Postgraduate Medicine

Volumn 110, Issue 3, 2001, Pages 42-53

  Kaynard, Alan ^a   Flora, Kenneth ^b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Oregon Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CIMETIDINE; ESOMEPRAZOLE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE;

BARRETT ESOPHAGUS; CLINICAL FEATURE; CONFERENCE PAPER; DRUG EFFICACY; ESOPHAGOSCOPY; ESOPHAGUS PH; ESOPHAGUS STRICTURE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LIFESTYLE; QUALITY OF LIFE; REFLUX ESOPHAGITIS; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0034835828     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2001.09.1017     Document Type: Conference Paper

References (19)

1. Methodological aspects of evaluation of quality of life in upper gastrointestinal diseases
2. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: Suggested disease management guidelines
3. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
4. Gastroesophageal reflux disease presenting with intractable nausea
5. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy
6. Aspiration of solid food particles into lungs of patients with gastroesophageal reflux and chronic bronchial disease
7. Asthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcome
8. Symptoms in gastro-oesophageal reflux disease
9. Barrett's esophagus: A prevalent, occult complication of gastroesophageal reflux disease
10. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease
11. Ambulatory 24-h esophageal pH monitoring: Normal values, optimal thresholds, specificity, sensitivity, and reproducibility
12. Clinical esophageal pH recording: A technical review for practice guideline development
13. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain
14. Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations: Results of a multicenter, placebo-controlled, doseranging study
15. Proton pump inhibitors and acid-related diseases
16. Long-term treatment with omeprazole for refractory reflux esophagitis: Efficacy and safety
17. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis
18. A comparison of five maintenance therapies for reflux esophagitis
19. Persistent acid secretion during omeprazole therapy: A study of gastric acid profiles in patients demonstrating failure of omeprazole therapy